<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04827498</url>
  </required_header>
  <id_info>
    <org_study_id>21/289-E</org_study_id>
    <nct_id>NCT04827498</nct_id>
  </id_info>
  <brief_title>Myocardial Ischemia Without Obstructive Coronary Stenoses</brief_title>
  <official_title>Myocardial Ischemia Without Obstructive Coronary Stenoses: A Prospective Observational Study With Invasive Coronary Pressure and Flow Measurements and Endothelial Function Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital San Carlos, Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundacion Investigacion Interhospitalaria Cardiovascular</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital San Carlos, Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronary-related myocardial ischemia can result from obstructive epicardial stenosis or&#xD;
      non-obstructive causes including coronary microcirculatory dysfunction and vasomotor&#xD;
      disorders. This prospective study has been created in order to provide knowledge in the field&#xD;
      of non-obstructive coronary artery disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All-comer patients referred for coronary physiological assessment with pressure-flow&#xD;
      measurements and acetylcholine endothelial function test, aimed to investigate different&#xD;
      aspects of non-obstructive coronary artery disease, will be enrolled. Coronary hemodynamics&#xD;
      during adenosine or acetylcholine evaluation will be measured either with a physiology wire&#xD;
      equipped with pressure and temperature sensors (Abbott), or with a physiology wire equipped&#xD;
      with pressure sensor and Doppler (Philips). Non-endothelium-dependent functional assessment&#xD;
      will be performed with intravenous or intracoronary adenosine administration following the&#xD;
      standard practice. Endothelium-dependent functional assessment will be performed with&#xD;
      intracoronary acetylcholine bolus administration following the standard practice, which&#xD;
      includes continuous 12-lead ECG monitorization. Microcirculatory dysfunction and vasomotor&#xD;
      disorders will be diagnosed according to the criteria from the last European expert consensus&#xD;
      on Ischaemia with Non-Obstructive Coronary Arteries (INOCA). Medical therapy will be adjusted&#xD;
      on the basis of physiology study results and patients will be followed at 30 days, 1-, 2- and&#xD;
      5-years either at the outpatient clinic or by telephone contact. The Seattle Questionnaire of&#xD;
      Angina will be applied during follow-up for obtaining an objective characterisation of the&#xD;
      angina status.&#xD;
&#xD;
      OBJECTIVES OF THE STUDY:&#xD;
&#xD;
        -  To investigate the coronary hemodynamics across the spectrum of coronary&#xD;
           microcirculatory dysfunction.&#xD;
&#xD;
        -  To investigate the coronary hemodynamics across the spectrum of vasomotor disorders.&#xD;
&#xD;
        -  To investigate the impact of coronary microcirculatory dysfunction on clinical outcomes&#xD;
           and patient symptoms at long-term follow-up.&#xD;
&#xD;
        -  To investigate the impact of coronary vasomotor disorders on clinical outcomes and&#xD;
           patient symptoms at long-term follow-up.&#xD;
&#xD;
        -  To investigate the impact of a stratified medical therapy (guided by invasive physiology&#xD;
           study) on patient symptoms.&#xD;
&#xD;
        -  To investigate the role of microcirculatory dysfunction and vasomotor disorders in&#xD;
           different settings of ischemic heart disease (i.e., recurrent angina despite successful&#xD;
           percutaneous coronary intervention; myocardial infarction without obstructive coronary&#xD;
           artery disease; left ventricular dysfunction (either systolic or diastolic) with or&#xD;
           without heart failure).&#xD;
&#xD;
        -  To develop new, alternative methods aimed to assess the coronary microcirculation.&#xD;
&#xD;
        -  To investigate the role of myocardial bridging on myocardial ischemia generating&#xD;
           mechanisms.&#xD;
&#xD;
        -  To document safety of intracoronary testing in routine clinical practice.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient-oriented composite outcome</measure>
    <time_frame>Up to 5 years</time_frame>
    <description>Incidence of a patient-oriented composite outcome, a composite of any death, nonfatal myocardial infarction, any ischemia-driven revascularization or hospitalization due to unstable angina pectoris</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vessel-oriented composite outcome</measure>
    <time_frame>Up to 5 years</time_frame>
    <description>Incidence of a vessel-oriented composite outcome, a composite of cardiac death, target-vessel related myocardial infarction or target-vessel revascularization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient symptoms burden</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Change in the Seattle questionnaire of angina scoring, associated to stratified medical treatment. Minimum is 0 and maximum is 100 and lower scores indicate worse outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence of any death</measure>
    <time_frame>Up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence of cardiac death</measure>
    <time_frame>Up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence of nonfatal myocardial infarction</measure>
    <time_frame>Up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence of ischemia-driven revascularization</measure>
    <time_frame>Up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety of invasive comprehensive coronary functional testing with adenosine and acetylcholine</measure>
    <time_frame>During procedure</time_frame>
    <description>Adverse events / complications linked to invasive functional testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency room visit due to angina episode</measure>
    <time_frame>Up to 5 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Resting and hyperemic mean aortic pressure (mmHg)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary guiding catheter during physiology assessment under adenosine administration and acetylcholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Resting and hyperemic mean intracoronary distal pressure (mmHg)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under adenosine administration and acetylcholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Resting and hyperemic mean coronary flow (mean transit time or cms/sec)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under adenosine administration and acetylcholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Resting and hyperemic coronary microcirculatory resistance (units)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under adenosine administration and acetylcholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Resting Pd/Pa (units)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under resting conditions</description>
  </other_outcome>
  <other_outcome>
    <measure>Resting full cycle ratio (units)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under resting conditions</description>
  </other_outcome>
  <other_outcome>
    <measure>Instantaneous wave-free ratio (units)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under resting conditions</description>
  </other_outcome>
  <other_outcome>
    <measure>Fractional flow reserve (units)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under hyperemia</description>
  </other_outcome>
  <other_outcome>
    <measure>Coronary flow reserve (units)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under adenosine administration and acetylcholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Resistive reserve ratio (units)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with the coronary physiology wire under adenosine administration and acetylcholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Location of vasospasm into the coronary vessel (proximal, mid or distal)</measure>
    <time_frame>During procedure</time_frame>
    <description>Detected under acetylcholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of transient ischemic ECG changes (T wave inversion, ST depression, ST elevation)</measure>
    <time_frame>During procedure</time_frame>
    <description>Observed under acetylcholine provocation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in diameter vessel (in percentage)</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured with quantitative coronary angiography under acetylcholine and nitroglycerin intracoronary administration</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Myocardial Ischemia</condition>
  <condition>Non-Obstructive Coronary Atherosclerosis</condition>
  <condition>Microvascular Coronary Artery Disease</condition>
  <condition>Vasospastic Angina</condition>
  <condition>Myocardial Bridging</condition>
  <arm_group>
    <arm_group_label>Myocardial ischemia without obstructive coronary stenosis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Invasive coronary endothelium-dependent and non-endothelium-dependent physiological assessment</intervention_name>
    <description>Coronary hemodynamics and vessel anatomical measures obtained during adenosine and acetylcholine evaluation with a dedicated physiology wire</description>
    <arm_group_label>Myocardial ischemia without obstructive coronary stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The target population consists of patients with clinically indicated invasive physiological&#xD;
        measures of coronary pressure and flow with adenosine and acetylcholine for the assessment&#xD;
        of myocardial ischemia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent available.&#xD;
&#xD;
          -  Age ≥ 18 years.&#xD;
&#xD;
          -  Patient eligible for invasive physiological assessment with adenosine and / or&#xD;
             acetylcholine.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemodynamic instability.&#xD;
&#xD;
          -  Anticipated technical issues for physiology wire measurements.&#xD;
&#xD;
          -  Culprit vessel of acute coronary syndrome&#xD;
&#xD;
          -  Contraindications for adenosine administration.&#xD;
&#xD;
          -  Contraindications for acetylcholine test.&#xD;
&#xD;
          -  Reduced life expectancy (less than 1 year).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hernan Mejia-Renteria, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Hospital Clinico San Carlos</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javier Escaned, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Hospital Clinico San Carlos</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hernan Mejia-Renteria, MD, PhD</last_name>
    <phone>+34 913303283</phone>
    <email>hmejiarenteria@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>April 23, 2021</last_update_submitted>
  <last_update_submitted_qc>April 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital San Carlos, Madrid</investigator_affiliation>
    <investigator_full_name>Hernan D. Mejia-Renteria</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Stenosis</mesh_term>
    <mesh_term>Angina Pectoris, Variant</mesh_term>
    <mesh_term>Myocardial Bridging</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The study contemplates the possibility of sharing data with other researchers who have similar objectives. IPD to be shared includes demographic data, vessel characteristics, invasive coronary physiology data and outcome measures, appropriately anonymized.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Throughout the development of the study</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

